Quantbot Technologies LP Rubius Therapeutics, Inc. Transaction History

Quantbot Technologies LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 07, 2022	SELL	$0.46 - $1.29 $5,428 - $15,222	-11,800 Reduced 72.84%	4,400 $1,000
Q2 2022 Aug 09, 2022	BUY	$0.79 - $5.98 $4,977 - $37,674	6,300 Added 63.64%	16,200 $13,000
Q1 2022 May 16, 2022	BUY	$4.25 - $10.4 $7,650 - $18,720	1,800 Added 22.22%	9,900 $54,000
Q4 2021 Feb 11, 2022	BUY	$9.68 - $17.74 $60,016 - $109,987	6,200 Added 326.32%	8,100 $78,000
Q3 2021 Nov 09, 2021	BUY	$17.6 - $25.91 $21,120 - $31,092	1,200 Added 171.43%	1,900 $33,000
Q2 2021 Aug 12, 2021	BUY	$22.26 - $28.43 $15,582 - $19,901	700 New	700 $17,000

325

Ticker RUBY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 90,357,000
Description
Rubius Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of red cell therapeutics (RCTs) for the treatment of patients with severe diseases. The company is developing RTX-240 and RTX-224 for the treatment of solid tumors cancer; and RTX-aAPC to treat cancers. It is also developing RTX-321 for the treatmen...

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

Stay updated on Quantbot Technologies LP with notifications on news.